Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 01, 2016 11:30 ET | Source: AstraZeneca PLC

Dealing by Person Closely Associated

1 November 2016 15:30 Transaction by Person Closely Associated with a Person Discharging Managerial Responsibilities Disclosure under Articles 19(3) and 19(6) of the EU Market Abuse Regulation On...
October 31, 2016 10:19 ET | Source: AstraZeneca PLC

AZ completes US Aralez agreement for Toprol-XL

31 October 2016 13:45 ASTRAZENECA COMPLETES AGREEMENT WITH ARALEZ FOR BETA-BLOCKER MEDICINE TOPROL-XL IN THE US AstraZeneca today announced the completion of...
October 27, 2016 12:02 ET | Source: AstraZeneca PLC

AstraZeneca Head and Neck Cancer Trials

27 October 2016 16:50 ASTRAZENECA HEAD AND NECK CANCER TRIALS Following the recent update on clinicaltrials.gov, AstraZeneca confirms that the US FDA has placed a partial clinical hold on the...
October 26, 2016 02:00 ET | Source: AstraZeneca PLC

Positive results in AstraZeneca Lynparza trial

This announcement contains inside information 26 October 2016 07:00 LYNPARZA PHASE III SOLO-2 TRIAL SHOWS SIGNIFICANT PROGRESSION-FREE SURVIVAL BENEFIT Trial studied Lynparza as maintenance...
October 18, 2016 02:00 ET | Source: AstraZeneca PLC

FDA ACCEPTS FOR REVIEW NEW DRUG APPLICATION FOR SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9) FOR THE TREATMENT OF HYPERKALAEMIA

18 October 2016 [07:00] AstraZeneca today announced that the US Food and Drug Administration (FDA) has accepted a complete re-submission of a New Drug Application (NDA) for sodium zirconium...